Introduction
Cisplatin, cis-diamminedichloroplatinum(II) (CDDP), a square planar Pt(II) complex remains in the frontline of inorganic chemotherapeutic agents for the treatment for cancer [1] [2] [3] [4] . The clinical effectiveness of CDDP is limited by considerable side effects and the emergence of drug resistance. Consequently, a number of second-and third-generation CDDP analogues including carboplatin, oxaliplatin, nedaplatin, heptaplatin, lobaplatin and satraplatin were developed for use in the treatment of various cancers. These advances have spurred a surge of investigations to identify new inorganic agents (non-platinum metals) for use in chemotherapy with improved specificity and decreased toxic side effects.
Accordingly, non-platinum metallodrugs such as Ru, Cu, Au, Pd, Fe, Co, Ti, Ga, Ni, Rh, Ir, Sn, Os, Zn, V, Ag, Re, Mo and lanthanide complexes have emerged and been shown to exhibit comparable or better cytotoxic properties accompanied by different specificities towards cancer cells, and by a more favourable pharmacological and toxicological profiles [5, 6] . Review articles describing the application of transition metal complexes as anticancer agents are available in the literatures [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] .
On the other hand, organotin(IV) compounds have displayed diverse medicinal applications such as anti-viral, anti-microbial, anti-parasitic, anti-hypertensive, antihyperbilirubinemia and anti-cancer activities, apart from their standard uses as biocides, catalyzers and stabilizers [24] [25] [26] [27] [28] [29] . Compared to standard drugs, the majority of organotin(IV) carboxylates discussed in the literature have shown superior anticancer activity against various cell lines. Additionally, some of them have demonstrated distinct anticancer activity even against CDDP-resistive cancer cells. Organotin(IV) compounds with pronounced medicinal properties also exhibit drawbacks such as reproductive toxicity, neurotoxicity and other toxic effects apart from poor water solubility; however, these can be circumvented by a rational design of the structures of the compounds, but the vital point still remains the activity. In practice, organotin(IV) compounds are dissolved in DMSO and diluted with test medium prior to in vitro testing. Nevertheless, the limited solubility needs to be further enhanced in a way comparable to CDDP, which also shows limited water solubility. It is therefore important to find more effective and safer organotin(IV) compounds for therapeutic use by designing and synthesizing new compounds and to find suitable means of their delivery to the bio-targets. In this pursuit, recently a novel biocompatible strategy of drug delivery employing nano-structured silicabased material loaded with triphenyltin(IV) compound was used. This resulted in an increase in efficacy of the drug and the pattern of action leads to the non-aggressive suppression of melanoma tumor growth with non-recognizable toxicity toward normal tissue [30] . While the potency of a drug is a very important consideration, drug selectivity towards cancer cells is key to ensuring both safety and effectiveness [31] . Additionally, the mechanism of action of organotin(IV) compounds in achieving cell death remains uncertain, and hence additional work is essential to identify the actual apoptotic or necrotic pathways.
In view of the above, careful functionalization of a series of organotin compounds was undertaken. In this endeavour, six pro-ligands (i) isomeric 2-, 3- in increased cellular accumulation [32, 33] . The incorporation of the triphenyltin(IV) moiety in the molecule offers much higher activities when compared with titanocene derivatives and CDDP [34] [35] [36] . Thus, it is expected that the modification of the carboxylate ligands in the current series by incorporating SnPh 3 can optimize the cytotoxicity [37, 38] while varying the location of the triphenyltin ester can modulate the activity at a specific target. In this context, cytotoxic properties of series of a [Ph 3 Sn(L n )] complexes [L n = L 3-5 (8-10) and L 6-8 (11) (12) (13) ], were determined towards the MDA-MB-231 (human breast cancer) and HeLa (human cervical cancer) cell lines. To realize the mechanistic/mode of cell death objective, an additional series of experiments were conducted: (i) the cytotoxic activity was examined by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay (ii) the ability of the test compounds to generate ROS (reactive oxygen species) in the cells was examined using DCFH-DA (dichlorodihydro-fluorescein diacetate) dye (iii) apoptosis or mode of cell death was detected by Hoechst 33342/PI (propidium iodide) and annexin V-PI assay and (iv) cell cycle arrest by the compounds were examined by FACS (fluorescence-activated cell sorting) studies. The biological results indicated that the triphenyltin(IV) compounds show potent cytotoxicity which can be modulated either by varying the positions of the triphenyltin(IV) ester across a series or switching from triphenyltin(IV)-diazobenzoato-to-iminobenzoato-ligands. The present studies in this chapter demonstrated that the triphenyltin(IV) compounds exert their cytotoxic effect by elevating intracellular ROS generation as discussed below. Scheme 3.1 Generic structures with numbering protocol of pro-ligands L n H (n = 3-8) and tin phenyl moiety.
Synthesis of triorganotin(IV) compounds
A general method was followed for the synthesis of compounds 8-13. In a typical procedure, a mixture of Ph 3 SnOH and the appropriate pro-ligands L n H (n = 3-8) in a 1:1 stoichiometric ratio was heated to reflux in anhydrous toluene (50 mL) for 8 h in a round bottom flask equipped with a Dean-Stark apparatus and a water-cooled condenser. The reaction mixture was filtered while hot and the solvent was removed using a rotary evaporator. The residue was washed, boiled with hexane, filtered and dried in vacuo. The residue upon crystallization using appropriate solvent(s) yielded the desired product.
Spectroscopic characterization of triorganotin(IV) compounds
This section deals with the spectroscopic characterization of triphenyltin(IV) compounds.
The compounds 8-13 have been characterized by IR, 1 H, 13 C and 119 Sn NMR spectroscopic In the present investigation, potential for influencing cytotoxicity was the motivation for combining the effects of triphenyltin esters, being located in ortho-, metaand para-positions of molecules, with a diazenyl-or its isoelectronic imino group linking the aryl moieties (Scheme 3.1). Thus, six pro-ligands containing diazenyl-and iminogroups were selected, as these are likely to impart efficacious biological activities [39] [40] [41] . [46, 47] as evidenced by 119 Sn NMR which in each case featured a sharp singlet in the narrow range of -107.3 to -109.5 ppm.
Molecular structures of ligand and triorganotin(IV) compounds
Pro-ligand L 6 H and two representative compounds Ph 3 SnL 4 (9) and Ph 3 SnL 7 (12) were analyzed by single crystal X-ray crystallography while the crystallographic structures of In the molecular packing, supramolecular chains mediated by comparatively strong aryl-C-H…O(carbonyl) interactions are formed along [1 1 1], ( Fig. 3.2a ). The chains are connected into supramolecular tubes by methyl-C-H…π(aryl) contacts ( Fig. 3 .2b), and these pack with no specific interactions between them; the closest separations between aryl rings being >4.8 Å ( Fig. 3.2c ). The molecular structure of the diazo analogue of L 6 H, A crystal structure determination is available for 8 [45] . The weakly associated O2 atom in the distorted tetrahedral geometry is 2.827(3) Å from tin, i.e. further away than in 12, a result that might be correlated with steric pressure. The structure of the tri-n-butyl analogue is also known [49] . This is a polymeric compound as a result of bidentate, [52] . No precedents exist for organotin compounds with the meta-and para-isomeric carboxylate ligands.
Cytotoxicity Studies

MTT assay
The efficacy of triphenyltin(IV) compounds in suppressing tumor cells and advancing apoptosis has been well recognized [24] [25] [26] [27] [28] [29] . Cytotoxic data for 8 and its pro-ligand L 3 H on HCV29T (human bladder carcinoma) cell line has been reported briefly [45] . In the present investigation, the in vitro cytotoxic activities were evaluated using the MTT assay after incubation of 24 h. IC 50 values are given in Table 3 
Induction of ROS in MDA-MB-231 and HeLa cells
ROS are generally considered to be deleterious to cells, but ROS also have an important role in regulating signal transduction pathways and gene expressions. However, to effectively target cancer cells specific ROS-sensing signalling pathways that mediate the diverse stress-regulated cellular functions need to be identified [53, 54] . Organotin(IV)
compounds are known to induce apoptosis by increasing the intracellular ROS level [55] .
The level of ROS induced in MDA-MB-231 and HeLa cells by 8 and 10 at concentrations of 0.5, 1.0 and 1.5 µM, and 5 at concentrations of 0.6, 0.8 and 1.0 µM, respectively, were monitored using the probe DCFH-DA. DCFH-DA hydrolyzes to 2,7dichlorodihydrofluorescein (DCFH) in live cells, which in turn is oxidized to 2,7dichlorofluorescein (DCF) in the presence of ROS, exhibiting a green fluorescence [56, 57] .
As compared to the control, a noteworthy increase in ROS level was induced by 8 and 10
(b)
displayed an elevated level of ROS generation in a dose-dependent manner in the respective cell lines with respect to the control, which could be one of the reasons that apoptosis is promoted in these cells. Further, generation of ROS was also measured in normal HEK293 cells at their IC 50 concentration obtained against cancer cell lines and it was observed that the compounds did not induce increased ROS production ( Fig. 3.10) , as compared to the cancer cells ( Fig. 3.9 ) besides a few cells showing basal ROS induction. Table 3 .2)
Assessment of nuclear morphology during apoptosis by Hoechst 33342 and PI staining
The 
Control Control
pink chromatin that is mainly condensed or fragmented. The results also indicated that apoptotic cell death increases in a dose-dependent manner compared to the control. 
Apoptosis analysis by flow cytometry
The annexin V-PI assays clearly indicated that 8, 10 and 12 induces apoptosis. At the IC 50 concentrations of 8 and 10, the increase in early apoptotic cell population was observed from 2.24% (control) to 9.49% and 18.18%, respectively, in MDA-MB-231 cells.
In the case of Hela cells, the increase in early apoptotic cell population was from 0.60%
(control) to 9.49% at the IC 50 concentration (0.8 µM) and to 10.45% at 1µM. including their characterization and spectroscopic data are described below.
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Synthesis of 3-[(E)-{[4-(dimethylamino)phenyl]methylidene}amino]benzoic acid (L 7 H)
A similar synthetic procedure to that used for L 6 H was used [42] except that anthranilic acid was replaced by 3-aminobenzoic acid. The crude product was then recrystallized from methanol to give brown powder in 65% yield. M.p.: 200-202 C. Anal.
calc. for C 16 13 
Synthesis of 4-[(E)-{[4-(dimethylamino)phenyl]methylidene}amino]benzoic acid (L 8 H)
A similar synthetic procedure to that used for L 6 H was used [42] except that anthranilic acid was replaced by 4-aminobenzoic acid. The crude product was then recrystallized from methanol to give a golden yellow powder in 66% yield. M. exchanged due to presence of water in the solvent. 13 
Synthesis of triorganotin(IV) compounds
A typical method for the synthesis of triphenyltin(IV) complexes is described in section 3.2 and the characterization data are given below.
Synthesis of Ph 3 SnL 3 (8)
The synthesis of 8 has been reported earlier [45] 
Chemicals used for the preparations
Physical measurements
Melting points were measured using a Büchi melting point apparatus M-560 and are uncorrected. Carbon, hydrogen and nitrogen analyses were performed with a Perkin- 
X-ray crystallography
Single crystals suitable for X-ray crystal structure determination were obtained from methanol (L 6 H and 9) and acetonitrile (12) solutions of the respective compounds by slow evaporation of the solvent at room temperature. Intensity data for L 6 H, 9 and 12 were collected at room temperature on an Agilent Xcalibur Eos Gemini diffractometer equipped with a CCD area detector and graphite-monochromated MoK radiation ( = 0.71073 Å).
Data reduction and empirical absorption correction, based on a multi-scan technique, was by standard methods [61] . The structures were solved by direct methods using SHELXS97 [62] and refinement (anisotropic displacement parameters and C-bound hydrogen atoms in idealised positions) of each structure was carried out on F 2 by using the full-matrix least- special features, but some evidence was found for disorder in the C41-phenyl ring of 12, as manifested by shorter than usual C-C bond lengths. However, multiple positions for the atoms comprising the C41-ring were not resolved in this room temperature determination.
Crystal data and refinement details are given in 
Experimental protocol for cytotoxicity tests
Stability assessment of triphenyltin(IV) compounds 8-13 in DMSO solution
As mentioned in the introduction, the organotin(IV) compounds are dissolved in DMSO and diluted with test medium prior to in vitro testing and hence the stabilities of the triphenyltin(IV) compounds 8-13 were assessed in DMSO prior to the cytotoxic studies.
The absorbance spectra obtained from UV/Vis were monitored for 23 days (Fig. 3.14 
MTT assays
MDA-MB-231, HeLa and HEK293 cell lines were used to determine cytotoxicity.
The cell viability was checked by the MTT assay (colorimetric assay) based on the conversion of the yellow tetrazolium salt MTT to purple formazan crystals after reaction with mitochondrial dehydrogenase of metabolically active cells [67] . Briefly, 1x10 4 HeLa, MDA-MB-231 and HEK293 cells were seeded in three different 96 well cell culture plates. After 24 h, the culture medium was replaced by a fresh medium containing various concentrations of L n H and 8-13 and, incubated further for 24 h in 5% CO 2 humidified atmosphere. The medium was then removed and 100 μL of fresh medium and 10 μL of 5 mg mL -1 MTT in phosphate buffered saline (PBS, pH 7.4) were added to each well and incubated further for 2 h. Finally, 100 µL of DMSO was added to dissolve the MTT formazan crystals followed by incubation for 30 min. Similarly; the MDA-MB-231 and HeLa cells were exposed to various concentrations of CDDP as the drug control.
The absorbance of samples was measured at 570 nm with a plate reader. The percent cell inhibition was calculated with respect to control and IC 50 (inhibitory concentration) values obtained were represented as mean ± SD for triplicates.
ROS generation assay
The intracellular ROS level was assessed using DCFH-DA. Briefly, MDA-MB-231, HeLa and HEK293 cells were seeded in 6 well plates at a density of 4x10 5 cells per well for 24 h at 37 °C in a humidified atmosphere of 5% CO 2 . Then, HeLa cells were treated with compound 12 with concentrations of 0.6, 0.8 and 1.0 µM (based on the IC 50 value) for 24 h. Similarly, the MDA-MB-231 cells were then treated with compounds 8
and 10 with concentrations of 0.5, 1.0 and 1.5 µM (based on the IC 50 values) and HEK293 cells were treated with compounds 8, 10 and 12 at the IC 50 concentrations obtained against the cancer cells for 24 h at 37 °C maintaining the humidified atmosphere of 5% CO 2 . Then, the cells were washed with PBS and exposed in DCFH-DA dye (10 µM) for 30 min at 37
ºC. The cell samples were subjected to inverted fluorescence microscopy and DCF fluorescence was detected ( ex = 485 nm;  em = 530 nm) and photographed.
Fluorescence staining of MDA-MB-231 and HeLa cells for the detection of apoptotic cell death
The MDA-MB-231 and HeLa cells (2 x10 5 ) were seeded in 6 well plates and kept for 24 h at 37 °C in a humidified atmosphere of 5% CO 2 . Thereafter, cells were treated with the indicated concentrations of 8, 10 and 12 for 24 h. Subsequently, cells were washed with 1 x PBS and stained with Hoechst 33342 (10 μg mL -1 ) and PI (15 μg mL -1 )
solutions and incubated at 37 °C for 20 min. Cells were then washed with PBS and images of nuclear morphology were recorded using an inverted fluorescent microscope in red and blue channels.
Flow cytometry analysis of apoptosis
The MDA-MB-231 and HeLa cells (2x10 5 ) were seeded in 12 well plates separately, as described above, and then treated with various concentrations of 8, 10 and 12, respectively, for 24 h and incubated in a CO 2 incubator. After incubation, cells were washed with ice-cold PBS and harvested. The cells were centrifuged at 3000 rpm for 10 min. The cells were re-suspended in 100 µL of annexin binding buffer wherein 5 µL of annexin V Alexa fluor 488 conjugate and 1 µL of PI (100 µg mL -1 ) was added and incubated for 15 min at 37 °C in the dark. Finally, 400 µL of annexin binding buffer was added in each tube and the stained cells were analyzed by flow cytometry. 97
Cell cycle analysis
The MDA-MB-231 and HeLa cells (4x10 5 ) were seeded in 6 well plates as described above, and then treated with indicated concentrations of 8, 10 and 12 for 24 h in DMEM with 10% FBS. Cells were then washed, trypsinized and fixed in ice-cold 70% ethanol and kept overnight at -20 °C. Then, the cells were washed twice in ice-cold PBS, and 500 μL of staining solution (0.1% (v/v) Triton X-100 solution, PI (1 mg mL -1 ) solution and RNase (10 mg mL -1 in PBS)) were added to each sample and incubated for 30 min at room temperature in the dark. After the staining procedure, the cell samples were assessed and the cell cycle distribution was analyzed using a FACS Aria II flow cytometer and analyzed using CELLQUEST software.
